Search

Author/Creator Oyen, W J G

1. 888PLesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC). (23rd October 2018)

Authors:
Verhoeff, S R; Es, S; Boon, E; van Helden, E; Angus, L; Elias, S; Oosting, S; Aarntzen, E; Brouwers, A; Heskamp, S; Hoekstra, O S; Verheul, H M; Van der Veldt, A A M; de Vries, E G E; Boerman, O; van der Graaf, W T A; Oyen, W J G; van Herpen, C M L
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. (19th November 2019)

Authors:
Horwich, A; Babjuk, M; Bellmunt, J; Bruins, H M; Reijke, T M De; Santis, M De; Gillessen, S; James, N; Maclennan, S; Palou, J; Powles, T; Ribal, M J; Shariat, S F; Kwast, T Van Der; Xylinas, E; Agarwal, N; Arends, T; Bamias, A; Birtle, A; Black, P C
Journal:
Annals of oncology
Issue:
Volume 30:Number 11(2019)
Page Start:
1697
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗